Glioblastoma multiforme (GBM): An overview of current therapies and mechanisms of resistance

W Wu, JL Klockow, M Zhang, F Lafortune… - Pharmacological …, 2021 - Elsevier
Glioblastoma multiforme (GBM) is a WHO grade IV glioma and the most common malignant,
primary brain tumor with a 5-year survival of 7.2%. Its highly infiltrative nature, genetic …

[HTML][HTML] Evidence-based recommendations on categories for extent of resection in diffuse glioma

P Karschnia, MA Vogelbaum, M van den Bent… - European Journal of …, 2021 - Elsevier
Surgical resection represents the standard of care in diffuse glioma, and more extensive
tumour resection appears to be associated with favourable outcome. Up to now, terminology …

Association of maximal extent of resection of contrast-enhanced and non–contrast-enhanced tumor with survival within molecular subgroups of patients with newly …

AM Molinaro, S Hervey-Jumper, RA Morshed… - JAMA …, 2020 - jamanetwork.com
Importance Per the World Health Organization 2016 integrative classification, newly
diagnosed glioblastomas are separated into isocitrate dehydrogenase gene 1 or 2 (IDH) …

Prognostic validation of a new classification system for extent of resection in glioblastoma: A report of the RANO resect group

P Karschnia, JS Young, A Dono, L Häni… - Neuro …, 2023 - academic.oup.com
Background Terminology to describe extent of resection in glioblastoma is inconsistent
across clinical trials. A surgical classification system was previously proposed based upon …

Human glioblastoma arises from subventricular zone cells with low-level driver mutations

JH Lee, JE Lee, JY Kahng, SH Kim, JS Park, SJ Yoon… - Nature, 2018 - nature.com
Glioblastoma (GBM) is a devastating and incurable brain tumour, with a median overall
survival of fifteen months,. Identifying the cell of origin that harbours mutations that drive …

Association of the extent of resection with survival in glioblastoma: a systematic review and meta-analysis

TJ Brown, MC Brennan, M Li, EW Church… - JAMA …, 2016 - jamanetwork.com
Importance Glioblastoma multiforme (GBM) remains almost invariably fatal despite optimal
surgical and medical therapy. The association between the extent of tumor resection (EOR) …

5-ALA and FDA approval for glioma surgery

CG Hadjipanayis, W Stummer - Journal of neuro-oncology, 2019 - Springer
Abstract The US Food and Drug Administration (FDA) approved 5-aminolevulinic acid (5-
ALA; Gleolan®; photonamic GmbH and Co. KG) for use as an intraoperative optical imaging …

[HTML][HTML] DeepSeg: deep neural network framework for automatic brain tumor segmentation using magnetic resonance FLAIR images

RA Zeineldin, ME Karar, J Coburger, CR Wirtz… - International journal of …, 2020 - Springer
Purpose Gliomas are the most common and aggressive type of brain tumors due to their
infiltrative nature and rapid progression. The process of distinguishing tumor boundaries …

Current standards of care in glioblastoma therapy

C Fernandes, A Costa, L Osório, RC Lago… - Exon …, 2017 - exonpublications.com
Glioblastoma (GBM) is the most common primary malignant brain tumor in adults.
Regardless of ideal multidisciplinary treatment, including maximal surgical resection …

Surgical oncology for gliomas: the state of the art

N Sanai, MS Berger - Nature Reviews Clinical Oncology, 2018 - nature.com
Surgical resection remains the mainstay of treatment for patients with glioma of any grade.
Maximal resection of the tumour is central to achieving long-term disease control; however …